Fig. 1From: Mesenchymal stromal cells plus basiliximab, calcineurin inhibitor as treatment of steroid-resistant acute graft-versus-host disease: a multicenter, randomized, phase 3, open-label trialTreatment plan of SR aGVHD patients in the MSC and control group. CNI calcineurin inhibitor, CR complete response, PR partial response, NR no responseBack to article page